CAPR · Capricor Therapeutics, Inc. · Executive Compensation
$6.60
-0.05 (-0.68%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$384.30M
Shares
58.14M
Volume · Oct 20
2M
Avg daily vol (3M)
7M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Linda Marban | Chief Executive Officer | $1,657,032 |
| Anthony "A.J." Bergmann | Chief Financial Officer | $792,192 |
| Karen G. Krasney | Executive Vice President & General Counsel | $762,605 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Karen G. Krasney | Executive Vice President & General Counsel | $340,327 |
| Anthony "A.J." Bergmann | Chief Financial Officer | $252,827 |
| Linda Marban | Chief Executive Officer | $228,919 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Linda Marban | Chief Executive Officer ^^ | $377,471 |
| Karen G. Krasney | Executive Vice President & General Counsel ^^ | $351,890 |
| Anthony "A.J." Bergmann | Chief Financial Officer | $273,700 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Kelliher | director | Appointed | 2025-05-27 |
| Philip Gotwals, Ph.D. | director | Appointed | 2025-05-27 |
| Karimah Es Sabar | director | Appointed | 2025-05-27 |
| Paul Auwaerter, M.D. | director | Appointed | 2025-05-27 |
| George W. Dunbar, Jr. | director | Appointed | 2025-05-27 |
| David B. Musket | director | Appointed | 2025-05-27 |
| Linda Marbán, Ph.D. | director | Appointed | 2025-05-27 |
| Frank Litvack, M.D. | director | Appointed | 2025-05-27 |
| Michael Kelliher | member of the Board | Appointed | 2023-09-06 |
| Philip Gotwals, Ph.D. | member of the Board | Appointed | 2023-07-24 |
| Paul Auwaerter | member of the Board | Appointed | 2023-07-13 |
| Louis Manzo | member of the Board of Directors | Resigned | 2023-07-13 |
Leadership
- Linda Marban CEO, Board Member
- Frank Litvack Chairman, Board Member
- Anthony "A.J." Bergmann CFO
- Karen G. Krasney General Counsel
- David B. Musket Board Member
- Frank Litvack, M.D. Board Member
- George W. Dunbar Jr Board Member
- George W. Dunbar, Jr. Board Member
- Karimah Es Sabar Board Member
- Linda Marbán, Ph.D. Board Member
- Michael Kelliher Board Member
- Paul Auwaerter Board Member
- Paul Auwaerter, M.D. Board Member
- Philip Gotwals Board Member
- Philip Gotwals, Ph.D. Board Member